Clinical products
Premium antibodies (GMP)
Intracellular staining
Surface staining
Hematology
Kits
Lysing solutions
Multicolor cocktails
Single color antibodies
Immunodeficiency
Kits
Lysing solutions
Mitogens
Multicolor cocktails
Single color antibodies
Reproductive immunology
Kits
Lysing solutions
Multicolor cocktails
New products
Allergy
Kits
Recombinant allergens
Allergen extracts
Other allergens
Research products
Antibodies
CD and related antigens
Blood group antigens
Multicolor cocktails
Serum, plasma, and secreted proteins
Cytoskeleton and ECM
Isotype controls
MHC antigens
Nucleus
Other intracellular antigens
Small organic molecules
Tags and labels
Microbiology and virology
Accessory reagents
Annexin V
DNA-binding probes
Lineage cocktail
Lysing solutions
Recombinant proteins
Streptavidin
Recombinant allergens
Animal
Food
House Dust Mite
Mold
Pollen
Venom
Kits
New products
Dry Reagents
About exbio
Company
OEM and Commercial Supplies
Events and Conferences
Blog
Inquiries
Technical resources
International distributors
Contact
Jobs
IVDR
E-mail
*
Password
*
Remember me
Forgotten password
Log in
Register
E-mail
Send request
Log in
Exbio
—
Research products
—
Recombinant allergens
—
Venom
—
rVes v 1 (Vespula vulgaris 1.0101)
rVes v 1 (Vespula vulgaris 1.0101)
Regulatory status
RUO
Format
Purified Azide Free
Application
ELISA, FC, WB
Variant
0.1 mg
10-P183-C100
In stock
242.00 USD
Variant
0.1 mg
10-P183-C100
In stock
242.00 USD
Contact distributor
Product details
Images
SDS download
Application
ELISA, FC, WB
Description
Recombinant protein rVes v 1 is expressed in S2 cells (Drosophila). DNA sequence encoding 314 AAs was fused with Strep-tag at the N-terminus. A calculated molecular mass of recombinant protein is 34,9 kDa.
Contents
Recombinant protein rVes v 1 - 1 vial (0.1 mg), lyophilized.
Reconstitute with sterile deionized water with or without azide.
Preparation
Purified by sequential steps of ion exchange and affinity chromatography. Lyophilized from a 0.2 μm filtered solution in Storage buffer (100 mM Tris, 150 mM NaCl, 0.01% Tween 20, pH 8.0).
Storage and handling
Store at -20°C to -80°C. Reconstitute in sterile deionized water. Use reconstituted product immediately or aliquot for further storage at -20°C to -80°C.
Exbio licence note
Unless indicated otherwise, all products are For Research Use Only and not for diagnostic use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s. © 2019 EXBIO Praha, a.s. All rights reserved.
Flow cytometry dot-plot staining pattern of rVes v 1 recombinant allergen stimulated human peripheral whole blood lymphocytes and basophils of a proven allergic donor stained using anti-human CD63 (MEM-259) FITC and anti-human CD203c (NP4D6) PE antibodies of BasoFlowEx kit.
Recombinant allergen rVes v 1 purity verification. 5 µg of rVes v 1 with > 95 % purity checked by Coomassie Brilliant Blue stained SDS-PAGE.
Reactivity of rVes v 1, rVes v 2, and rVes v 5 with sIgE antibodies in plasma a patient with confirmed presence (routine clinical test) of specific IgE antibodies to common wasp venom allergen extract.
Western blotting analysis was performed on recombinant allergens rVes v 1, rVes v 2, and rVes v 5 mixed and heated (100°C, 5 min) with reducing SDS loading buffer. Sample was resolved using 15% SDS-PAGE gel. Nitrocellulose membrane blot was stained with Ponceau S to verify protein transfer. After thorough washing and blocking steps, the membrane was incubated with plasma of an allergic patient (1:10). Captured rVes v 1, rVes v 2, and rVes v 5 sIgE antibodies were detected by biotinylated anti-human IgE secondary antibody (2 μg/ml) followed by IRDye 800CW Streptavidin (1:5000).
Further SDS language mutations available for download below. Please contact us with request for additional languages on info@exbio.cz
MPAb_SDS_v1_GB.pdf
MPAb_SDS_v1_TR.pdf
MPAb_SDS_v6_AT.pdf
MPAb_SDS_v6_CH.pdf
MPAb_SDS_v6_CS.pdf
MPAb_SDS_v6_EN.pdf
MPAb_SDS_v6_ES.pdf
MPAb_SDS_v6_FR.pdf
MPAb_SDS_v6_IT.pdf
MPAb_SDS_v6_NO.pdf
MPAb_SDS_v6_PL.pdf
MPAb_SDS_v6_PT.pdf
MPAb_SDS_v6_SE.pdf
MPAb_SDS_v6_SK.pdf
MPAb_SDS_v6_SL.pdf
MPAb_SDS_v7_DE.pdf
Variant
0.1 mg
10-P183-C100
In stock
242.00 USD
Variant
0.1 mg
10-P183-C100
In stock
242.00 USD
Contact distributor
Datasheet download
Bulk requests
Technical support for this product
Related products
10-P184-C100
rVes v 2 (Vespula vulgaris 2.0101)
-134%
Clone
Reg. status
RUO
Application
ELISA, WB
0.1 mg
242.00 USD
10-P185-C100
rVes v 5 (Vespula vulgaris 5.0101)
-134%
Clone
Reg. status
RUO
Application
ELISA, FC, WB
0.1 mg
242.00 USD
Continue to checkout
×
Zavřít